Epidemiology study about travelers' diarrhea in Japan using Verigene system
Not Applicable
- Conditions
- diarrheatravellers'
- Registration Number
- JPRN-UMIN000029761
- Lead Sponsor
- ational Centre for Global Health and Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 102
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have diarrhea before trip. Patients who have underlying illness with diarrhea.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What bacterial pathogens and virulence factors are identified in travelers' diarrhea via the Verigene system in Japan?
How does the Verigene system's molecular detection improve diagnostic accuracy for travelers' diarrhea compared to traditional methods?
Which biomarkers correlate with antibiotic resistance patterns in travelers' diarrhea cases analyzed in JPRN-UMIN000029761?
What adverse events are associated with travelers' diarrhea in Japan, and how does the Verigene system inform management strategies?
How does the Verigene system's pathogen profiling compare to other nucleic acid amplification tests in travelers' diarrhea epidemiology?